OverviewSuggest Edit

IsoRay Inc. is a national isotope-based medical company. With its patented radioisotope technology, the Company offers products including Cesium-131 seeds and other relevant treatment medicine for cancer and other malignant diseases. Its subsidiary, IsoRay Medical Inc., is the sole producer of Cesium-131 brachytherapy seeds. Brachytheraphy is when cancer-fighting medical radioisotopes are implanted in or around the affected tissue so to be as close to cancer as possible.

TypePublic
Founded1998
HQRichland, US
Websiteisoray.com
Employee Ratings2.7

Latest Updates

Employees (est.) (Feb 2019)38
Revenue (FY, 2018)$5.9 M(+25%)
Share Price (May 2019)$0.5 (+5%)

Isoray Office Locations

Isoray has an office in Richland
Richland, US (HQ)
350 Hills St #106
Show all (1)

Isoray Financials and Metrics

Isoray Revenue

Isoray's revenue was reported to be $5.92 m in FY, 2018
USD

Revenue (Q3, 2019)

1.9m

Gross profit (Q3, 2019)

879.0k

Gross profit margin (Q3, 2019), %

45.7%

Net income (Q3, 2019)

(1.1m)

EBIT (Q3, 2019)

(1.2m)

Market capitalization (22-May-2019)

31.0m

Closing stock price (22-May-2019)

0.5

Cash (31-Mar-2019)

4.1m
Isoray's current market capitalization is $31 m.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

4.6m4.8m4.8m5.9m

Cost of goods sold

4.4m4.4m4.6m3.9m4.1m

Gross profit

167.4k129.2k838.0k1.8m

Gross profit Margin, %

4%3%18%31%
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Revenue

1.0m1.3m1.1m1.0m1.3m1.2m1.5m1.6m1.6m1.9m1.9m

Cost of goods sold

1.1m1.1m1.1m1.1m1.2m1.2m1.1m1.0m1.0m989.0k946.0k1.0m964.0k1.0m1.1m1.0m

Gross profit

(54.8k)83.5k48.0k(1.0k)293.0k265.0k531.0k609.0k524.0k765.0k879.0k

Gross profit Margin, %

(5%)7%4%0%23%22%35%39%34%40%46%
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

7.7m5.2m10.1m5.9m2.6m

Accounts Receivable

1.2m

Inventories

359.7k404.0k334.4k323.0k494.0k

Current Assets

19.2m16.3m13.6m10.3m5.4m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Cash

5.3m4.4m23.7m2.1m1.6m678.9k5.7m8.5m6.7m5.1m4.0m3.0m2.4m2.2m3.2m4.1m

Accounts Receivable

1.1m1.1m

Inventories

436.2k426.3k387.0k407.5k460.6k476.7k457.3k380.0k381.0k314.0k453.0k459.0k458.0k487.0k494.0k533.0k

Current Assets

6.9m5.9m25.1m13.7m15.3m14.3m13.2m14.9m13.2m11.9m8.9m7.4m6.3m11.3m9.8m8.4m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(6.0m)(3.7m)(4.7m)(6.2m)(6.7m)

Depreciation and Amortization

470.9k68.0k80.0k

Inventories

45.8k(144.3k)(23.4k)89.0k23.0k

Accounts Payable

142.3k(76.6k)112.3k18.0k761.0k
USDY, 2019

Revenue/Employee

50.6k

Financial Leverage

1.2 x
Show all financial metrics

Isoray Online and Social Media Presence

Embed Graph

Isoray News and Updates

Isoray Announces Second Quarter Fiscal 2019 Financial Results

Record Revenue and Gross ProfitRevenue Increased 24% Year-Over-Year

Radiotherapy Market 2018 Trend and Key Players Analysis: Isoray, View Ray, Fuji Holdings, Philips Healthcare and Forecasts Up To 2023

Global Radiotherapy Market- by treatment type (X-rays, External beam radiotherapy, proton therapy and others), by application (Breast cancer, prostate cancer, lung cancer and others); - Forecast to 2023 Posted via Industry Today. Follow us on Twitter @IndustryToday

Isoray Blogs

Isoray Announces Record Third Quarter Fiscal 2019 Financial Results

Record Revenue and Gross Profit Revenue Increased 22% Year-Over-Year RICHLAND, WASHINGTON – May 9, 2019 — Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced its financial result…

Isoray To Announce Third Quarter Fiscal 2019 Financial Results on May 9, 2019

Conference Call is May 9 at 4:30 p.m. ET/1:30 p.m. PT RICHLAND, WASHINGTON – May 1, 2019 – Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in brachytherapy powering expanding treatment options throughout the body, today announced that it will host a conference call to d…

Dr. Peter Orio Showcases the Elegance and Simplicity of Brachytherapy for Prostate Cancer

Boston Herald Reporter Alexi Cohan recently joined Dr. Peter Orio on the “front lines” in order to learn more about brachytherapy for prostate cancer treatment. This article details the brachytherapy procedure process and the benefits that it brings both the patient and their clinicians. From the ar…

Isoray Collaborates With Texas Oncology to Fill Void in Training Programs For Next Generation of Brachytherapists

RICHLAND, WASHINGTON – April 16, 2019 – Isoray, Inc. (NYSE American: ISR), a medical technology company and innovator in brachytherapy powering expanding treatment options throughout the body, today announced a new training collaboration with Texas Oncology. The collaboration brings together the inn…

Webinar: Transitioning Isotopes for Prostate Brachytherapy – April 17th, 2019

The post Webinar: Transitioning Isotopes for Prostate Brachytherapy – April 17th, 2019 appeared first on Isoray - Treating Prostate Cancer with Brachytherapy.

Transitioning isotopes for prostate brachytherapy: Dr. Bernard Taylor, Texas Oncology

Transition concerns should not stop you from adding Cesium to your prostate brachytherapy practice. With a thoughtful approach to planning and the right support, you can seamlessly upgrade your prostate brachytherapy to the power of Cesium. The post Transitioning isotopes for prostate brachytherapy:…
Show more

Isoray Frequently Asked Questions

  • When was Isoray founded?

    Isoray was founded in 1998.

  • How many employees does Isoray have?

    Isoray has 38 employees.

  • What is Isoray revenue?

    Latest Isoray annual revenue is $5.9 m.

  • What is Isoray revenue per employee?

    Latest Isoray revenue per employee is $155.9 k.

  • Who are Isoray competitors?

    Competitors of Isoray include Sensus Healthcare, Medical Device Works and Eximis Surgical.

  • Where is Isoray headquarters?

    Isoray headquarters is located at 350 Hills St #106, Richland.

  • Where are Isoray offices?

    Isoray has an office in Richland.

  • How many offices does Isoray have?

    Isoray has 1 office.